2 stories in the last 7 days
The latest parabilis news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks parabilis across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Parabilis Medicines raised $670 million in the biggest biotech IPO on record, topping Moderna's $604 million. The stock soared 58% on its first day. The company targets previously undruggable proteins using its Helicon platform, led by former Johnson & Johnson R&D head Mathai Mammen.
Parabilis completed the largest venture capital-backed biotech initial public offering, according to PitchBook data. The IPO marks a significant milestone for the biotech sector. The company raised substantial capital through the public offering.
Summaries by ByteBrief